Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial and in rhesus monkeys
919  

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial and in rhesus monkeys

The mosaic Ad26/Ad26 plus gp140 HIV-1 vaccine induced comparable and robust immune responses in humans and rhesus monkeys, and it provided significant protection against repetitive heterologous SHIV challenges in rhesus monkeys. This vaccine concept is currently being evaluated in a phase 2b clinical efficacy study ...

July 09, 2018
News  
Campaign essentials for World Immunization Week 2018
795  

Campaign essentials for World Immunization Week 2018

Immunization saves millions of lives and is widely recognized as one of the world’s most successful and cost-effective health interventions. Yet, there are more than 19 million unvaccinated or under-vaccinated children in the world, putting them at serious risk of these potentially fatal diseases. Of ...

April 25, 2018
News